Prognostic biomarker testing rates for patients with CLL and SLL is low, indicating the need for more comprehensible treatment options, according to data presented at the virtual ONS Congress.
Data from the 2021 ONS Congress reveals the telehealth coordination progress has provided advancements in the Gastrointestinal Medical Oncology Program.
A patient case study, presented at the 2021 ONS Congress, supports the confirmation that a genetic diagnosis leads to the appropriate management and surveillance approach in GIST, NF1 and other…
According to data presented at the 2021 ONS Congress, researchers have observed patients with gastrointestinal (GI) cancers experience moderate to high levels of sleep disturbance during chemotherapy…
Stay in the know.
OncNet Newsletter